| Prevalence of psychoactive substance use Prevalence of medication use Prevalence of drug use Drug prevention Treatment supply Treatment demand Health consequences Harm reduction Drug-related crimes Drug market Drug use and prison Monitoring of publications Attitudes to legal framework changes |
Source: National population adult survey on attitudes and use of psychoactive substances among the general population (aged 15-64). The survey was conducted in the period October-November 2024 on behalf of and with the methodological support of the National Focal Point on Drugs and Drug Addictions by Sova 5 Agency, covering 4002 individuals across the country, and using the “face-to-face” method with a tablet.
Lifetime prevalence of psychoactive substance use among the general population (adults aged 15-64) (by sex, 2024)
| Type of psychoactive substances | Males | Females | Total | Lower (%) | Upper (%) | Lower (number) | Upper (number) |
| Tobacco products (total) | 65.4 | 57.3% | 61.4% | 59.9% | 62.9% | 2 390 000 | 2 511 000 |
| Cigarettes | 64.2% | 56.6% | 60.4% | 58.9% | 61.9% | 2 351 000 | 2 472 000 |
| Electronic cigarettes (vape) | 30.6% | 33.5% | 32.1% | 30.6% | 33.5% | 1 222 000 | 1 337 000 |
| Tobacco heating devices | 10.5% | 10.7% | 10.6% | 9.7% | 11.6% | 386 000 | 462 000 |
| Hookah | 19.9% | 12.2% | 16.1% | 14.9% | 17.2% | 596 000 | 687 000 |
| Alcohol | 98.0% | 88.0% | 93.1% | 92.3% | 93.9% | 3 684 000 | 3 746 000 |
| Anabolic steroids | 0,5% | 0,3% | 0,7% | 11 200 | 28 700 |
Lifetime prevalence of psychoactive substance use among the general population (adults aged 15-64) (by settlement, 2024)
| Type of psychoactive substances | Sofia (capital) | District city | Non-district city | Village | Total |
| Tobacco products (total) | 65.5% | 61.4% | 61.0% | 58.1% | 61.4% |
| Cigarettes | 64.9% | 60.0% | 60.3% | 57.1% | 60.4% |
| Electronic cigarettes (vape) | 32.7% | 30.2% | 34.3% | 31.4% | 32.1% |
| Tobacco heating devices | 12.0% | 10.4% | 10.1% | 10.3% | 10.6% |
| Hookah | 16.6% | 17.4% | 14.1% | 16.2% | 16.1% |
| Alcohol | 92.9% | 93.3% | 93.5% | 92.5% | 93.1% |
| Anabolic steroids | 0.8% | 0.7% | 0.3% | 0.2% | 0.5% |
Lifetime prevalence of psychoactive substance use among the general population (adults aged 15-64) (by age groups, 2024)
| Type of psychoactive substances | 15-24 (males) | 15-24 (females) | 15-24 (total) | 25-34 (males) | 25-34 (females) | 25-34 (total) |
| Tobacco products (total) | 69.7% | 60.1% | 65.0% | 61.2% | 59.9% | 60.6% |
| Cigarettes | 64.6% | 57.2% | 61.0% | 61.2% | 59.6% | 60.4% |
| Electronic cigarettes (vape) | 57.0% | 50.2% | 53.6% | 33.0% | 37.7% | 35.4% |
| Tobacco heating devices | 18.5% | 17.7% | 18.1% | 16.0% | 14.8% | 15.4% |
| Hookah | 48.7% | 30.2% | 39.5% | 38.5% | 24.1% | 31.1% |
| Alcohol | 93.9% | 82.6% | 88.3% | 98.1% | 81.3% | 89.4% |
| Anabolic steroids | 0.8% | 0.8% |
| Type of psychoactive substances | 35-44 (males) | 35-44 (females) | 35-44 (total) | 45-54 (males) | 45-54 (females) | 45-54 (total) | 55-64 (males) | 55-64 (females) | 55-64 (total) |
| Tobacco products (total) | 65.2% | 56.9% | 60.9% | 68.9% | 54.2% | 61.8% | 61.9% | 56.9% | 59.6% |
| Cigarettes | 65.2% | 56.9% | 60.9% | 67.3% | 53.2% | 60.5% | 61.9% | 56.9% | 59.6% |
| Electronic cigarettes (vape) | 26.5% | 26.6% | 26.5% | 29.3% | 30.5% | 29.9% | 16.9% | 28.8% | 22.4% |
| Tobacco heating devices | 10.5% | 9.0% | 9.7% | 9.3% | 7.2% | 8.3% | 3.1% | 8.1% | 5.4% |
| Hookah | 17.9% | 10.1% | 13.8% | 6.1% | 3.3% | 4.7% | 4.9% | 1.4% | 3.3% |
| Alcohol | 99.3% | 88.1% | 93.5% | 99.0% | 93.7% | 96.4% | 98.6% | 91.0% | 95.0% |
| Anabolic steroids | 0.3% | 0.4% | 0.3% |